| (Values in U.S. Thousands) | Mar, 2017 | Dec, 2016 | Sep, 2016 | Jun, 2016 | Mar, 2016 |
| Sales | -9,999,000 | 850 | 740 | 730 | 730 |
| Sales Growth | -1,176,451.56% | +14.86% | +1.37% | unch | +19.67% |
| Net Income | -9,999,000 | -6,170 | -29,050 | -20,280 | -33,650 |
| Net Income Growth | -161,958.35% | +78.76% | -43.24% | +39.73% | -77.67% |
Great Basin Scientific Inc. (GBSND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Great Basin Scientific, Inc. is a molecular diagnostics company. It is focused on improving patient care through the development and commercialization of its patented, molecular diagnostic platform designed to test for infectious disease, especially hospital-acquired infections. Great Basin Scientific, Inc. is headquartered in Salt Lake City, Utah.